CAR T-cell therapy involves modifying a patient's own T cells to express a receptor specific to cancer cells. These engineered T cells are then expanded in the lab and reintroduced into the patient’s body, where they target and kill cancer cells. This therapy has shown remarkable success in treating certain types of blood cancers, such as acute lymphoblastic leukemia (ALL).
